Annexin V-FITC staining for detecting apoptosis

The Annexin V apoptosis detection protocol provides a reliable method for identifying early apoptotic cells using Annexin V-FITC staining. This technique exploits the calcium-dependent binding of Annexin V to phosphatidylserine (PS), which translocates to the outer leaflet of the plasma membrane during early apoptosis. The protocol is compatible with both suspension and adherent cells and can be combined with propidium iodide (PI) to distinguish between apoptotic and necrotic populations. Designed for use with flow cytometry, this method offers rapid, sensitive, and quantitative analysis of cell death. Abcam’s protocol is optimized for use with their Annexin V-FITC Apoptosis Detection Kit (ab14085), ensuring reproducibility and high-quality results in apoptosis research.

Introduction to Annexin V apoptosis assay

Apoptosis, or programmed cell death, is a fundamental biological process critical for development, immune regulation, and tissue homeostasis. Detecting apoptosis accurately is essential in fields such as cancer research, drug development, and immunology. The Annexin V-FITC assay is a widely used method for early apoptosis detection due to its specificity and ease of use. This protocol leverages the high affinity of Annexin V for phosphatidylserine, a hallmark of early apoptotic cells, allowing for sensitive detection of the early stages of apoptosis through phosphatidylserine externalization. When combined with PI, researchers can differentiate between live, apoptotic, and necrotic cells, enabling effective dead cell discrimination using flow cytometry. This protocol provides a robust and accessible approach for apoptosis analysis using flow cytometry.

Background and principles

During early apoptosis, phosphatidylserine (PS), normally confined to the inner leaflet of the plasma membrane, is externalized to the cell surface. This loss of membrane asymmetry in the cell membrane is a hallmark of early apoptosis. Annexin V, a 35–36 kDa protein, binds PS in a calcium-dependent manner. By conjugating Annexin V to fluorescein isothiocyanate (FITC), apoptotic cells can be detected via flow cytometry. Propidium iodide (PI), a DNA-binding dye, is excluded by intact cell membranes but penetrates late apoptotic or necrotic cells. Thus, dual staining with Annexin V-FITC and PI enables discrimination between viable cells and live cells (Annexin V−/PI−), early apoptotic cells (Annexin V+/PI−, also referred to as PI negative), and late apoptotic or necrotic cells (Annexin V+/PI+). This allows for accurate identification of each cell state, including viable cells, live cells, and apoptotic cells. In late-stage apoptosis, the loss of membrane integrity permits PI entry, distinguishing these cells from early apoptotic and necrotic populations. This principle underpins the Abcam Annexin V apoptosis detection protocol, which utilizes cytometric analysis and flow cytometric analysis to quantify apoptotic cell populations.

The exposure of phosphatidylserine (PS) residues (usually hidden within the plasma membrane) on the cell’s surface is an early event in apoptosis and can be used to detect and measure apoptosis. During apoptosis, PS is translocated from the cytoplasmic face of the plasma membrane to the cell surface, reflecting changes in cell membrane asymmetry. Annexin V has a strong, Ca²⁺-dependent affinity for PS and, therefore, can be used as a probe for detecting an apoptotic cell.

This is an example protocol for PS exposure detection using Annexin V, based on the protocol provided in Annexin V-FITC Apoptosis Detection Kit (ab14085). When working with a specific kit, you should always use the protocol provided on the datasheet as it has been designed for optimal results with the product.

Reagents:

• 1X Annexin V binding buffer
• Annexin V-FITC
• Optional: propidium iodide
• 2% formaldehyde
• Optional: trypsin (for adherent cells)

Stage 1 - Cell incubation with annexin V-FITC

Steps

Induce apoptosis via the desired method.

Collect cells by centrifugation.

• You will need to collect 1–5 x 10⁵ cells, depending on the volume your experiment requires.

Resuspend cells in 500 µL of 1X Annexin V binding buffer.

Add 5 µL of annexin V-FITC

• You can also add 5 µL of propidium iodide (PI) at this step, should you want to analyze PI staining later.

Incubate at room temperature for 5 min in the dark.

Steps

Induce apoptosis via the desired method.

Collect cells by centrifugation.

• You will need to collect 1–5 x 10⁵ cells, depending on the volume your experiment requires.

Gently trypsinize and wash cells once with serum-containing media

• This should be done before incubation with annexin V-FITC (steps 4 and 5).

Resuspend cells in 500 µL of 1X Annexin V binding buffer.

Add 5 µL of annexin V-FITC

• You can also add 5 µL of propidium iodide (PI) at this step, should you want to analyze PI staining later.

Incubate at room temperature for 5 min in the dark.

Stage 2 - Analyze annexin V-FITC binding

Steps

Analyze annexin V-FITC binding via flow cytometry

• Ex = 488 nm and Em = 350 nm using FITC signal detector (usually FL1)

If propidium iodide was added, analyze PI staining by the phycoerythrin emission signal detector (usually FL2).

Steps

Place the cell suspension on a glass slide.

• Cover the cells with a glass coverslip.

Invert the coverslip on a glass slide and visualize cells.

• Cells can also be washed with 1X Annexin V binding buffer and fixed in 2% formaldehyde before visualization.

Observe cells under a fluorescence microscope using a dual filter set for FITC and rhodamine.

• Cells with bound annexin V-FITC will show green staining in the plasma membrane.
• Cells that have lost membrane integrity will show red staining (PI) throughout the nucleus and a halo of green staining (FITC) on the cell surface (plasma membrane).

Comparison to other methods

Compared to TUNEL assays or caspase activity measurements, the Annexin V-FITC assay offers a faster and less complex workflow. While TUNEL detects DNA fragmentation resulting from internucleosomal cleavage and caspase assays measure enzymatic activity, Annexin V staining identifies apoptosis at an earlier stage by detecting PS exposure. Unlike western blotting or ELISA, which require cell lysis and are endpoint assays, with ELISA using a substrate solution for colorimetric detection, Annexin V-FITC allows real-time, live-cell analysis. Additionally, when combined with PI, it provides a more comprehensive view of cell viability. LDH and MTT assays, which assess cell proliferation and metabolic activity, rely on the integrity of cell membranes to measure viable cells. Mitochondrial assays can evaluate mitochondrial membrane potential and mitochondrial dysfunction, both of which are important indicators of apoptosis. However, Annexin V-FITC does not provide mechanistic insights like caspase profiling. Overall, it is ideal for rapid, high-throughput apoptosis screening.

Applications for the detection of apoptotic cells

The Annexin V-FITC apoptosis assay is widely used in biomedical research to evaluate cell death in response to various stimuli, including drug treatments, radiation, and immune responses. It is particularly valuable in oncology for assessing chemotherapeutic efficacy and in immunology for studying T cell activation-induced cell death. The assay is also used to study inflammatory diseases such as Crohn's disease, where dysregulated apoptotic cell death plays a role in disease progression. The protocol is applicable in toxicology, stem cell research, and developmental biology. Its compatibility with flow cytometry enables high-throughput analysis of large cell populations, making it suitable for both basic research and preclinical studies. This assay is intended for research use only and is not for diagnostic or therapeutic purposes.

Limitations

While the Annexin V-FITC assay is highly effective for detecting early apoptosis, it has some limitations. It cannot distinguish between apoptosis and other forms of PS-exposing cell death, such as necroptosis. The assay is also sensitive to calcium concentration, requiring precise buffer conditions. Additionally, Annexin V binding is reversible, which may affect signal stability during extended analysis. The method does not provide information on upstream apoptotic pathways or caspase activation. Furthermore, flow cytometry equipment is required, which may not be accessible in all labs. Despite these limitations, the assay remains a gold standard for early apoptosis detection.

Troubleshooting

Common issues with the Annexin V-FITC assay include weak fluorescence, high background, or inconsistent staining. A weak signal may result from insufficient Annexin V-FITC concentration or expired reagents. Ensure proper storage and use fresh buffers. High background can stem from inadequate washing or non-specific binding; optimize washing steps and verify buffer composition. If cells appear Annexin V+/PI+, verify that apoptosis was not over-induced, leading to secondary necrosis. For adherent cells, avoid harsh trypsinization, which can damage membranes and affect staining. Always include appropriate controls: untreated cells, Annexin V-only, and PI-only samples to validate staining specificity and gating strategy.